Search

everythinglearnresearchcommunity

for

Search:↓

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Tocotrienol supplements significantly increased hair growth in people with hair loss.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

PRP therapy is effective for hair regrowth and improving hair quality with minimal side effects.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

The "Hair Rub Test" is an effective, easy way to track hair growth improvement during therapy.

Cornu cervi pantotrichum pharmacopuncture solution helps mice grow hair by increasing hair follicle cell growth and a growth factor important for hair development.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Oral mini-pulse methylprednisolone is an effective and safe treatment for alopecia areata.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

PRP can effectively treat hair loss, especially with optimal platelet count.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Early recognition and treatment of VATS in transplant patients improve outcomes.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.